IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.518
EU - Europa 7.150
AS - Asia 1.515
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 9
AF - Africa 8
Totale 17.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.214
IE - Irlanda 1.755
UA - Ucraina 1.688
IT - Italia 899
SE - Svezia 847
HK - Hong Kong 609
VN - Vietnam 491
FI - Finlandia 477
DE - Germania 438
RU - Federazione Russa 405
CA - Canada 297
GB - Regno Unito 242
CN - Cina 169
TR - Turchia 104
FR - Francia 75
CH - Svizzera 68
PL - Polonia 46
UZ - Uzbekistan 44
AT - Austria 43
NL - Olanda 29
RO - Romania 28
BE - Belgio 26
LB - Libano 22
SG - Singapore 21
GR - Grecia 20
PT - Portogallo 17
JP - Giappone 16
AU - Australia 14
CZ - Repubblica Ceca 14
EU - Europa 14
ES - Italia 9
AE - Emirati Arabi Uniti 8
AM - Armenia 7
BG - Bulgaria 7
BR - Brasile 5
NZ - Nuova Zelanda 5
TW - Taiwan 5
ID - Indonesia 3
IL - Israele 3
IQ - Iraq 3
LU - Lussemburgo 3
MX - Messico 3
CO - Colombia 2
ET - Etiopia 2
GH - Ghana 2
GL - Groenlandia 2
LT - Lituania 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AR - Argentina 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
IN - India 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
MC - Monaco 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
PH - Filippine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.234
Salva come PNG Salva come JPEG
Città #
Dublin 1.754
Chandler 1.691
San Mateo 1.102
Jacksonville 768
Hong Kong 605
Dong Ket 489
Medford 489
Princeton 486
Wilmington 366
Altamura 362
Andover 345
Lawrence 283
Perugia 272
Ottawa 263
Ann Arbor 242
Des Moines 135
Saint Petersburg 130
Norwalk 108
Izmir 104
Beijing 86
Shanghai 68
Ashburn 63
Helsinki 60
Boardman 57
Falls Church 55
San Paolo di Civitate 54
Woodbridge 37
Moscow 36
Redwood City 31
Amelia 25
Brussels 25
New York 24
San Diego 23
Dearborn 22
Redmond 21
Bucharest 20
Den Haag 19
Auburn Hills 18
Frankfurt Am Main 18
Chicago 16
Narni 16
Terni 16
Milan 15
Rome 15
Cardiff 12
Lausanne 12
London 11
Warsaw 11
Houston 10
Kiev 10
Hanover 9
Dubai 8
Tokyo 8
Bethesda 7
Edinburgh 7
Los Angeles 7
Philadelphia 7
Simi Valley 7
Yerevan 7
Amsterdam 6
Porto 6
Singapore 6
Stockholm 6
College Station 5
Hamilton 5
Timisoara 5
Vienna 5
Ashton-under-Lyne 4
Braga 4
Dallas 4
Frankfurt am Main 4
Fremont 4
Iowa City 4
Madrid 4
Melbourne 4
Poli 4
Silver Spring 4
Tappahannock 4
Auckland 3
Belfiore 3
Brandon 3
Chioggia 3
Costa Mesa 3
Fairfield 3
Leicester 3
Luxembourg 3
Montreal 3
Padova 3
Paris 3
Phoenix 3
Seyssinet-Pariset 3
Sofia 3
Southwark 3
Swindon 3
Tel Aviv 3
Wuhan 3
Yorktown 3
Accra 2
Addis Ababa 2
Atlanta 2
Totale 11.118
Salva come PNG Salva come JPEG
Nome #
Interventions for enhancing medication adherence. 120
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 118
1286 Prospective consecutive cases of venous thromboembolic diseases at the single Venous thromboembolic Unit of Reggio Emilia 114
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 114
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 85
Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen 84
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 79
I disordini congeniti ed acquisiti dell’emostasi e della fibrinolisi 78
Le trombofilie acquisite 77
Prothrombin 202120A mutation in Behcet’s disease 74
Thrombophilia and cerebral vein thrombosis 74
Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents 74
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 74
Serine base exchange enzyme in commercially available porcine lyophilised platelets: different effect of unfractionated and low molecular weight heparins 73
Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward. 73
Establishing the prevalence and prevalence at birth of hemophilia in males a meta-analytic approach using national registries 71
APTT evaluation in the presurgery screening: survey of 5000 patients 70
. The role of thrombophilic states in the bleeding tendency of patients with hemophilia 69
IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY 69
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 68
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 67
Prolonged antithrombin activity of low-molecular-weight heparins. Clinical implications for the treatment of thromboembolic diseases 67
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 67
ANTITHROMBOTIC PROPHYLAXIS IN ELDERLY PATIENTS ATRIAL FIBRILLATION ADMITTED TO INTERNAL MEDICINE WARDS IN ITALY: ADHERENCE TO GUIDELINES 66
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation 66
L’organizzazione del centro per il monitoraggio della terapia anticoagulante orale 65
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 65
Il monitoraggio della terapia anticoagulante orale 64
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. 64
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 64
Bioequivalence of B-domain deleted and plasma derived FVIII concentrates. 64
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 64
Sustained suppression of hepatitics C by pegylated Interferon (PEG-INF) and Ribavirin in hemophilic patients 63
Sindrome da anticorpi fosfolipidi. Descrizione di un caso clinico con trombosi atriale dx e revisione della casistica di Reggio Emilia 63
Systematic review of randomized controlled trials of prophylactic clotting factor concentrate in hemophilia 63
Genima study: genetic polymorphysms and myocardial infarction among italian young adults 62
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 62
ACP Journal Club. A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis. 62
The association between venous thromboembolism and physical inactivity in everyday life 62
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 62
Haemophilia A and B and other rare bleeding disorders: an Italian retrospective survey on the intracranial haemorrhagic episodes. 61
Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: a metanalysis 60
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulant 60
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 60
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332) 59
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 59
Influenza vaccination in patients on long-term anticoagulant therapy. 59
D-DIMER TO PREDICT THROMBOSIS RECURRENCE AFTER UNPROVOKED VENOUS THROMBOEMBOLISM: EFFECT OF PATIENT- AND D-DIMER-RELATED FACTORS ON RECURRENCE PREDICTION 59
D-DIMER TO PREDICT RECURRENCE AFTER A FIRST EPISODE OF UNPROVOKED VENOUS THROMBOEMBOLISM: COMPARISON OF AGGREGATE AND INDIVIDUAL PATIENT DATA META-ANALYSIS 59
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 59
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 58
Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children: A Systematic Review and Meta-Analysis of Observational Studies 58
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B 57
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 57
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 57
Risk factors for venous thromboembolism in patients undergoing elective neurosurgery 56
Studio GEMINA: ruolo dei polimorfismi genetici e dell'omocisteinemia nell'infarto del miocardico in giovani-adulti italiani 56
Low-molecular-weight heparin treatment and cancer: pooled analysis of 908 patients treated for three months 56
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS 56
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. 56
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus. 56
Prevention of venous thromboembolism after major orthhopedic surgery: summing up evidence about old and new antithrombotic agents 55
Oral Anticoagulants and small intestinal bacterial overgrowth 55
THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES 55
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY 55
Transition to a web-based architecture of the Italian hemophilia registry network. 55
Indoleamina 2,3 diossigenasi e tolleranza al fattore VIII in pazienti affetti da emofilia a grave. 55
Profilassi della trombosi venosa profonda in neurochirurgia 54
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C 54
Indoleanmine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor XIII: A Multi-Centre Pilot Study 54
Fattori prognostici di successo nell ‘Induzione di immunotolleranza (ITI) negli emofilici a con inibitore high-responding (HR). Uno score predittivo dal registro Italiano. 54
D-DIMER TO PREDICT THROMBOSIS RECURRENCE: COMPARISON OF AGGREGATE DATA AND INDIVIDUAL PATIENT DATA META-ANALYSES. 54
A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol. 54
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project 54
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparison with oral anticoagulant 53
The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venuos Thromboembolism (VTE); the Prospective Randomized 'Prolong' Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) 53
Eradicazione del virus C dell'epatite (HCV) dopo terapia combinata con Interferone Pegilato (PEG-INF) e Rivabirina in pazienti emofilici HIV negativi 53
AJP Journal Club: Perioperative LMW heparin does not reduce mortality after surgery more than unfractionated heparin in patients with cancer. 53
ACP Journal Club. The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 53
AICE. FINAL RESULTS FROM THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTERS (AICE) SURVEY ON THE CAUSES OF DEATH AMONG ITALIAN HEMOPHILIACS. 53
Case Report: Sequestro polmonare in un paziente con emofilia a grave HIV positivo. 53
Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B. 53
Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia a patients carrying f8 gene null mutations. 53
Influenza vaccination in patients on long-term anticoagulant therapy 53
Gemina study:genetic polymorphysms and myocardial infarction among italian young adults 52
Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony) 52
Systematic Review of Randomized Controlled Trials of Prophilactic Clotting Factor Concentrate in Hemophilia 52
RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS 52
Warfarin Optimal Duration Italian Trial Investigators. Three months versus one year of oral anticoagulant therapy for idiopatic deep venous thrombosis. 52
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 52
Venous thrombotic risk assessment among factor V Leiden carriers undergone a thrombophilic screening by different types of indications 52
Factor V Leiden and G20210A prothrombin allele are not associated with thrombosis in Behcet’s disease 51
Hyperhomcysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease 51
Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients 51
INDOLEAMINA 2,3 DIOSSIGENASI E TOLLERANZA AL FATTORE VIII IN PAZIENTI AFFETTI DA EMOFILIA A GRAVE. 51
Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study 51
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 50
Objectives and methodology: Guidelines of the ItalianSociety for Haemostasis and Thrombosis (SISET). 50
Replacement therapy with recombinant FIX – multicentre evaluation of current dosing practice in Italy. 50
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. 50
Totale 6.215
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.376
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019168 0 0 0 0 0 0 0 0 0 21 138 9
2019/20201.598 14 71 203 12 202 15 214 264 328 107 24 144
2020/20213.491 34 290 94 314 1.180 165 220 8 303 98 247 538
2021/20223.740 51 742 92 140 123 36 64 1.372 34 25 445 616
2022/20235.912 541 887 95 415 472 660 8 302 2.251 10 193 78
2023/20241.452 157 229 108 36 36 14 507 125 211 29 0 0
Totale 17.939